Feds Seek To Force Kabco Pharmaceuticals To Stop Selling Possibly Contaminated Supplements
August 15, 2012 Kyriaki (Sandy) Venetis With failure to clean up its manufacturing practices after years of federal warnings, Kabco Pharmaceuticals is now facing an injunction to stop producing and selling its dietary supplements.
Manufacturing photo from Kabco Pharmaceuticals.
The U.S. Justice Department filed the injunction accusing the company of implementing inferior product safety and manufacturing practices, and producing dietary supplements that are potentially dangerous to people’s health.
The products produced by the company include: Brewers Yeast Tablets, Dandelion Root Capsules, Night-Time Herb Capsules, Inositol Calcium & Magnesium Capsules, Vitamin C-500 with Rose Hip Time-Released Tablets, and Joint All Capsules.
An investigation by the U.S. Federal Food and Drug Administration found that, “The company did not review and investigate product complaints, and Kabco also failed to hold dietary supplements under conditions designed to prevent product mix-ups.”
In November 2010, the FDA sent a warming letter to Kabco citing a number of violations. The allegations included that the company “did not perform identity testing on any of the dietary ingredients” received from distributors, such as valerian root (a sedative for sleep problems and anxiety) and ginkgo biloba (an aide for memory and concentration improvement).
The FDA also accused the company of failing to indicate what steps it would take “regarding already distributed dietary supplements” made from untested ingredients.